DrugPatentWatch Database Preview
Drugs in Development Information for Pentastarch
» See Plans and Pricing
What is the development status for investigational drug Pentastarch?
Pentastarch is an investigational drug.
There have been 5 clinical trials for Pentastarch.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Shock, Shock, Traumatic, and Shock, Hemorrhagic. The leading clinical trial sponsors are Sangart, University of British Columbia, and Children's & Women's Health Centre of British Columbia.
Summary for Pentastarch
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-12-01) |
| Vendors | 0 |
Recent Clinical Trials for Pentastarch
| Title | Sponsor | Phase |
|---|---|---|
| Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients | Sangart | Phase 2 |
| Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients | Sangart | Phase 2 |
| Fluid Resuscitation in Early Septic Shock | Baxter Healthcare Corporation | Phase 2 |
Clinical Trial Summary for Pentastarch
Top disease conditions for Pentastarch
Top clinical trial sponsors for Pentastarch
US Patents for Pentastarch
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
